Bremelanotide (PT-141) was developed from the peptide hormone Melanotan II.
Most of the research has been targeted to women with female sexual dysfunction an it is effective medication in treating sexual dysfunction in both men (erectile dysfunction or impotence), it does not act upon the vascular system, but directly increases sexual desire via the nervous system.
Bremelanotide currently has no contraindications and is 80% effective in men don’t respond to Viagra or Cialis. For women, it causes a 50% increase in sexually satisfying experiences.
Bremelanotide 10mg/vial
Inject 2mg subcutaneously as needed, 30 minutes to 6 hours prior to sexual activity. The initial dose will establish a time frame for response. Men should start at 1mg and titrate up to and not exceed 2mg. Women should start at 2mg dosing protocol.
![DEUSTROPIN 4/12 (120iu) (Recombinant Human Growth Hormone [rDNA origin]) HGH](images/products/thumb/01_17.png)
![DEUSTROPIN 4/12 (120iu) (Recombinant Human Growth Hormone [rDNA origin]) HGH](images/products/thumb/02_40.png)
